Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coronary Artery Disease
|
1577 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Malignant neoplasm of stomach
|
615 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
Stomach Carcinoma
|
652 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||
cervical cancer
|
268 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
Cervix carcinoma
|
283 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 0.500 | 2 | 2015 | 2017 | |||||
Malignant tumor of cervix
|
245 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 0.500 | 2 | 2017 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 0.500 | 2 | 2015 | 2017 | |||||
Prostate carcinoma
|
1168 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Sepsis
|
144 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 1.000 | 2 | 2014 | 2014 | |||||
Septicemia
|
141 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.020 | 1.000 | 2 | 2014 | 2014 | |||||
Complete atrioventricular block
|
96 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Coronary Arteriosclerosis
|
440 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Coronary heart disease
|
1178 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Glaucoma, Primary Open Angle
|
222 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1 | 2017 | 2017 | ||||||
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
24 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Hematologic Neoplasms
|
60 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Intracranial Aneurysm
|
150 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Ischemic stroke
|
704 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Leukopenia
|
153 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Liver carcinoma
|
942 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Neutropenia
|
97 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Parkinson Disease
|
990 | 0.658 | 0.560 | 9 | 117715853 | 3 prime UTR variant | G/C | snv | 0.11 | 0.010 | 1 | 2019 | 2019 |